Anti-CCL14抗体(ab9845)

概述

  • 产品名称Anti-CCL14抗体
    参阅全部 CCL14 一抗
  • 描述
    兔多克隆抗体to CCL14
  • 经测试应用适用于: ELISA, WBmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    Highly pure (>98%) recombinant CCL14 (human Hemofiltrate CC Chemokine 1)

  • 常规说明


    CCL14 was first isolated from the hemofiltrate of patients with chronic renal failure. It has a 46% amino acid sequence identity with MIP-1a/MIP-1b and 29%-37% homology with other CC chemokines.

性能

相关产品

应用

Our Abpromise guarantee covers the use of ab9845 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
ELISA Use a concentration of 0.5 µg/ml.

To detect CCL14 by direct ELISA (using 100µl/well antibody solution) a concentration of at least 0.5µg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with compatible secondary reagents, allows the detection of 0.2 - 0.4 ng/well of recombinant CCL14.

WB Use a concentration of 0.1 - 0.2 µg/ml.

Used in conjunction with compatible secondary reagents the detection limit for recombinant CCL14 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.

靶标

  • 功能Has weak activities on human monocytes and acts via receptors that also recognize MIP-1 alpha. It induced intracellular Ca(2+) changes and enzyme release, but no chemotaxis, at concentrations of 100-1,000 nM, and was inactive on T-lymphocytes, neutrophils, and eosinophil leukocytes. Enhances the proliferation of CD34 myeloid progenitor cells. The processed form HCC-1(9-74) is a chemotactic factor that attracts monocytes eosinophils, and T-cells and is a ligand for CCR1, CCR3 and CCR5.
  • 组织特异性Expressed constitutively in several normal tissues: spleen, liver, skeletal and heart muscle, gut, and bone marrow, present at high concentrations (1-80 nM) in plasma.
  • 序列相似性Belongs to the intercrine beta (chemokine CC) family.
  • 翻译后修饰The N-terminal processed forms HCC-1(3-74), HCC-1(4-74) and HCC-1(9-74) are produced in small amounts by proteolytic cleavage after secretion in blood.
    HCC-1(1-74), but not HCC-1(3-74) and HCC-1(4-74), is partially O-glycosylated; the O-linked glycan consists of one Gal-GalNAc disaccharide, further modified by two N-acetylneuraminic acids.
  • 细胞定位Secreted.
  • Information by UniProt
  • 数据库链接
  • 别名
    • CC-1 antibody
    • CC-3 antibody
    • CCL14 antibody
    • CCL14_HUMAN antibody
    • chemokine (C-C motif) ligand 14 antibody
    • Chemokine CC-1/CC-3 antibody
    • chemokine CC1 antibody
    • chemokine CC3 antibody
    • chemokine HCC1 antibody
    • chemokine HCC3 antibody
    • CKb1 antibody
    • HCC-1(1-74) antibody
    • HCC-1(9-74) antibody
    • HCC-1/HCC-3 antibody
    • HCC-3 antibody
    • HCC1 antibody
    • HEMOFILTRATE CC CHEMOKINE 1 antibody
    • MCIF antibody
    • NCC-2 antibody
    • NCC2 antibody
    • new CC chemokine 2 antibody
    • SCYA14 antibody
    • SCYL2 antibody
    • small inducible cytokine subfamily A (Cys-Cys), member 14 antibody
    • Small-inducible cytokine A14 antibody
    • SY14 antibody
    see all

Anti-CCL14 antibody (ab9845)参考文献

ab9845 has not yet been referenced specifically in any publications.

Product Wall

Thank you for your enquiry. First, I'm pleased to hear that ab12326 is working out for you in Wetern blotting. Ab12326 has not yet been tested for application in IP. I do suggest that you submit a review regarding your experiences with the antibody - i...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"